Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Søgaard PP"'
Autor:
Gregersen CH; Explorative Formulation & Technologies, CMC Design and Development, LEO Pharma A/S, 2750 Ballerup, Denmark; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Mearraoui R; Explorative Formulation & Technologies, CMC Design and Development, LEO Pharma A/S, 2750 Ballerup, Denmark; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Søgaard PP; In Vitro Biology, Molecular Biomedicine, Research and early development, LEO Pharma A/S, 2750 Ballerup, Denmark., Clergeaud G; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Petersson K; Explorative Formulation & Technologies, CMC Design and Development, LEO Pharma A/S, 2750 Ballerup, Denmark., Urquhart AJ; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Simonsen JB; Explorative Formulation & Technologies, CMC Design and Development, LEO Pharma A/S, 2750 Ballerup, Denmark. Electronic address: jbsimonsen@gmail.com.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2024 Apr; Vol. 197, pp. 114219. Date of Electronic Publication: 2024 Feb 17.
Autor:
Tang Q; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Fakih HH; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Zain Ui Abideen M; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Hildebrand SR; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Afshari K; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Gross KY; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Sousa J; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Maebius AS; Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Bartholdy C; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark., Søgaard PP; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark., Jackerott M; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark., Hariharan V; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Summers A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Fan X; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Okamura K; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Monopoli KR; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.; Bioinformatics and Computational Biology Program, Worcester Polytechnic Institute, Worcester, MA, 01609, USA., Cooper DA; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.; Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Echeverria D; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Bramato B; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., McHugh N; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Furgal RC; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Dresser K; Department of Pathology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Winter SJ; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Biscans A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Chuprin J; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Haddadi NS; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Sherman S; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Yıldız-Altay Ü; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Rashighi M; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Richmond JM; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA., Bouix-Peter C; Aldena Therapeutics, London, E1 6RA, UK., Blanchard C; Aldena Therapeutics, London, E1 6RA, UK., Clauss A; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark., Alterman JF; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. Julia.Alterman@umassmed.edu., Khvorova A; RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. Anastasia.Khvorova@umassmed.edu.; Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. Anastasia.Khvorova@umassmed.edu., Harris JE; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. John.Harris@umassmed.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 04; Vol. 14 (1), pp. 7099. Date of Electronic Publication: 2023 Nov 04.
Autor:
Søgaard PP; Regenerative Medicine Department, LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark., Lind M; Explorative Formulation and Technologies, LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark., Christiansen CR; Regenerative Medicine Department, LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark., Petersson K; Explorative Formulation and Technologies, LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark., Clauss A; Regenerative Medicine Department, LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark., Caffarel-Salvador E; Regenerative Medicine Department, LEO Pharma A/S, Industriparken 55, 2750 Ballerup, Denmark.; LEO Science & Tech Hub, One Broadway, Cambridge, MA 02142, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2021 Oct 18; Vol. 13 (10). Date of Electronic Publication: 2021 Oct 18.
Autor:
Søgaard PP; MRC London Institute of Medical Sciences (LMS), London, UK.; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK., Gil J; MRC London Institute of Medical Sciences (LMS), London, UK. jesus.gil@imperial.ac.uk.; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK. jesus.gil@imperial.ac.uk.
Publikováno v:
Nature metabolism [Nat Metab] 2019 Mar; Vol. 1 (3), pp. 310-311.
Autor:
Søgaard PP; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK., Ito N; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK., Sato N; Institute for Genetic Medicine, Division of Molecular Oncology, Hokkaido University, Sapporo, Japan., Fujita Y; Institute for Genetic Medicine, Division of Molecular Oncology, Hokkaido University, Sapporo, Japan., Matter K; UCL Institute of Ophthalmology, University College London, London, UK., Itoh Y; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK yoshi.itoh@kennedy.ox.ac.uk.
Publikováno v:
Life science alliance [Life Sci Alliance] 2019 Feb 13; Vol. 2 (1). Date of Electronic Publication: 2019 Feb 13 (Print Publication: 2019).